STI Expert Hour Webinar – Injectable PrEP: From Clinical Trials to Real-World Implementation
Monday, September 22, 2025 11:00AM-12:30PM (PDT) 1.50 CME units at no cost Registration closes September 19, 2025 at 3:00PM (PT) Register Here
Presenters Oliver Bacon, MD, MPH Medical Director San Francisco City Clinic San Francisco Department of Public Health
Christopher Ruiz Biomedical Prevention Coordinator San Francisco City Clinic San Francisco Department of Public Health
Description:
In this timely STI expert hour, Dr. Oliver Bacon and Christopher Ruiz from San Francisco City Clinic will discuss injectable PrEP for HIV – including the newly adopted twice-yearly option, lenacapavir. Come learn about current injectable PrEP options, the evidence-base behind them, and real-world implementation considerations!
Learning Objectives:
Participants will be able to:
Summarize dosing, efficacy, and safety data for currently-available injectable PrEP options.
List at least two barrier and facilitators of long-acting PrEP implementation in clinical practice.
Analyze similarities and differences between lenacapvir and cabotegravir for HIV PrEP with the goal of optimizing provider counseling and patient choice.
To request an accommodation for this event, please email captc@ucsf.edu at least a week in advance of the event.
STI Clinical Update Webinar – Congenital Syphilis Scenarios: A case-based overview
April 28, 2025 12:00PM -1:15PM (PDT) CME not offered for viewing the webinar recording.
Course Description
This presentation reviews four separate cases of congenital syphilis (CS). Each case illustrates one of the four CS Scenarios, as defined by the Centers for Disease Control and Prevention (CDC). Through these cases, learners will gain an understanding of the diagnosis and management of the CDC CS Scenarios. The cases are shown from two viewpoints: a clinical pediatric infectious disease perspective and a public health medical officer standpoint.
Learning Objectives
Describe the diagnostic criteria for the four congenital syphilis scenarios, as described by the Centers for Disease Control and Prevention
Identify at least one public health resource for congenital syphilis management
Understand the different lab tests that can be used to evaluate an infant exposed to syphilis during pregnancy.
Presenters
Elizabeth Partridge, MS, MD, MPH Dr. Partridge is an Associate Clinical Professor of Pediatric Infectious Diseases at the UC Davis Medical Center (UCDMC) in Sacramento, CA. She provides inpatient and outpatient consultation for children with acute and chronic infections. Dr. Partridge serves as medical director of infection prevention for the UC Davis Children’s Hospital. Her clinical and research interests include hospital epidemiology & infection prevention. She has a special clinical interest in the prevention and management of congenital Syphilis infection.
Rosalyn Plotzker, MD, MPH Dr. Plotzker is an Assistant Professor in the UCSF Department of Epidemiology and Biostatistics and also performs high-resolution anoscopy at the UCSF Anal Neoplasia Clinic, Research, and Education (ANCRE) Center. She completed a Fellowship in Sexually Transmitted Diseases with the CAPTC and the California Department of Public Health (CDPH). She serves as a Public Health Medical Officer in the STD Control Branch at CDPH.
To request an accommodation for this event, please email captc@ucsf.edu at least a week in advance of the event.
Clinical Guidance: Infant and Child Follow-up After Exposure to Syphilis in Utero
Designed to support clinicians and public health practitioners, this resource provides detailed algorithms for the evaluation, treatment, and follow-up of neonates, infants, and children exposed to syphilis during pregnancy. Developed in alignment with the 2021 CDC STI Treatment Guidelines, the resource outlines step-by-step instructions for monitoring RPR/VDRL titers, interpreting titer trends, and ensuring thorough follow-up care for infants and children affected by syphilis.
Neisseria Gonorrhoeae (NG) Culture and Antimicrobial Susceptibility Testing (AST) Availability for California Providers
Designed for healthcare providers in California, this resource provides a detailed list of laboratories that offer Neisseria gonorrhoeae culture and/or antimicrobial susceptibility testing – both of which are recommended for managing suspected gonorrhea treatment failures and disseminated gonococcal infections.
CLIA-Waived Syphilis Point-of-Care Testing Options for Providers
This clinical resource outlines the CLIA-waived point-of-care testing options available for syphilis, including the Syphilis Health Check and the DPP HIV-Syphilis System. The document summarizes and compares the two CLIA-waived point-of-care tests, then answers frequently asked questions – including who can perform these tests, in what settings they may be most useful, and how to follow-up reactive point-of-care test results.
In the last installation of NNPTC’s 3 part Syphilis Series, learn from experts Dr. Jason Zucker of the New York City STI PTC & Dr. Erica Hardy of the Sylvie Ratelle STI/HIV PTC.
Case Based Discussions on Congenital Syphilis & Syphilis in Pregnancy
Learning Objectives
Describe the importance of interprofessional collaboration in sexual health care.
Describe current STD/HIV screening strategies including diagnostic algorithms.
Describe current STD/HIV treatment recommendations.
In the second installation of NNPTC’s three part Syphilis Series, learn from our NNPTC experts, Dr. Khalil Ghanem of the PTC at Johns Hopkins & Dr. Arlene Sena of the Southeast PTC.
Case based discussions of clinical conundrums
Experts walk through cases & make treatment decisions
Learning Objectives
Describe the importance of interprofessional collaboration in sexual health care.
Describe current STD/HIV screening strategies including diagnostic algorithms.
Describe current STD/HIV treatment recommendations.
STI Expert Hour Webinar: Shared Decision Making in Sexual Health
Tuesday, February 25, 2025 11:30AM-12:45PM (PST) 1.25 CME units at no cost
Recording currently unavailable. Please note: No CME available for viewing the webinar recording.
Presenter Patty Cason, MS, FNP-BC President, Envision Sexual and Reproductive Health
Course Description A plethora of national guidelines recommend shared decision making as a person-centered way to engage with patients who are making decisions about their health. The goal is for patients to benefit from the provider’s contribution of scientific information while being acknowledged as the experts on themselves. This session will provide a specific, detailed approach to this and language suggestions to operationalize shared decision-making conversations.
Learning Objectives
Define shared decision making
Describe three contributions a provider makes during a shared decision-making conversation
List four ways to acknowledge a patient
Opt-out screening is an approach where all patients are informed that HIV/STIs screening will be performed as part of routine medical care, unless the patient specifically declines. Included in the job aid are resources from various sources (including the CDC and CDPH), a workflow for a typical office visit, and guidelines for best practices.
Recent research has shown that opt-out guidelines increase screening rates and subsequent treatment for HIV and STIs (such as chlamydia, gonorrhea, and syphilis). This method reduces stigma, improves health equity, and opens the door for more comprehensive care.
Please join us for a morning half-day STI Intensive offered in-person and virtually at no cost at the University of California, San Francisco at the ZSFG campus. There will also be an in-person (only) afternoon wet-mount at the UCSF Parnassus campus available to a limited number of the morning-training participants at no cost. This event will cover topics including STI epidemiology, syphilis, mycoplasma genitalium, HPV, and biomedical STI prevention. Speakers will include faculty from CAPTC (UCSF), the San Francisco Department of Public Health, and the California Department of Public Health.
½ Day Didactic: Morning – Early Afternoon
Hybrid event being offered in-person at UCSF Pride Hall & Virtually by Zoom
Onsite breakfast and refreshments provided
CME will be offered at no cost
Topics will cover STI trends (national and California); biomedical STI prevention; syphilis cases; updates in STI management, with a focus on syphilis, mycoplasma genitalium and HPV.
Recording currently unavailable.
Wet Mount: Mid Afternoon-Evening
Previous microscopy skills are required to take this course. Registration prioritized for STI Intensive didactic attendees. Space limited to 12 max capacity.
In-person only training being offered at UCSF Parnassus Heights
3-hour laboratory course
CME will be offered at no cost
Topics will cover CLIA regulation, quality control, and interpretation vaginal wet mount (VWM) for common causes of vaginitis. Microscope footage of findings on VWM including trichomonads, yeast and clue cells associated with BV. Experiential training, including laboratory practicum on examination of saline and KOH vaginal wet mounts (VWM). Participants will have an opportunity for group discussion, explanation, and demonstration, as well as practice and return demonstration.
We use cookies to ensure that we give you the best experience on our website, but we also recognize the right to privacy. Please accept or disable cookies for this website.
